Embolización parcial del bazo en el síndrome de Felty
Intervencionismo para un síndrome clínico
Resumen
El síndrome de Felty comprende la asociación de artritis reumatoidea crónica, neutropenia y esplenomegalia. Esta última, cuando se asocia a hiperesplenismo, se caracteriza por el desarrollo de trombocitopenia, leucopenia, anemia o de todas. La embolización parcial endovascular del bazo puede ser una opción válida para el tratamiento del hiperesplenismo, pero no está exenta de riesgos. Presentamos el caso de un paciente joven, con artritis reumatoidea, síndrome de Felty e hiperesplenismo, a quien se realizó embolización parcial endovascular del bazo.Citas
I. Stock H, Kadry Z, Smith JP. Surgical management of portal hypertension in Felty’s syndrome: A case report and literature review. Journal of Hepatology 2009; 50:831–35.
II. Newman KA, Akhtari M. Management of autoim-mune neutropenia in Felty’s syndrome and systemic lupus erythematosus. Autoimmunity Reviews 2011; 10 (7):432-37.
III. Madoff DC, Denys A, Wallace MJ, Murthy R, Gup-ta S, Pillsbury EP, Ahrar BAK, Bessoud B, Hicks ME. Splenic Arterial Interventions: Anatomy, In-dications, Technical Considerations, and Potential Complications. RadioGraphics 2005; 25:191–211.
IV. Kumar A, Yoon J,Thakur V, Contractor S. Safety and efficacy of partial splenic embolization for hy-persplenism: a meta-analysis. Journal of Vascular and Interventional Radiology 2013; 24(4): S138.
V. Hidaka H, Kokubu S, Saigenji K, Isobe Y, Maeda T. Restoration of thrombopoietin production after partial splenic embolization leads to resolution of thrombocytopenia in liver cirrhosis. Hepatology Research 2002; 23(4):265-73.
VI. Balint GE, Balint PV. Felty’s syndrome. Best Prac-tice & Research Clinical Rheumatology 2004; 18 (5):631-45.
VII. Puapong D, Terasaki K, Lacerna M, Applebaum H. Splenic artery embolization in the management of an acute immune thrombocytopenic purpura–re-lated intracranial hemorrhage. Journal of Pediatric Surgery 2005; 40(5):869-71.
VIII. Narváez J, Domingo-Domenech E, Gómez-Va-quero C, López-Vives L, Estrada P, Aparicio M, Martín-Esteve I, Nolla JM. Biological Agents in the Management of Felty´s Syndrome. A Systematic Re-view. Seminars in Arthritis and Rheumatism 2012; 41(5):658-68.
IX. Killeen KL, Shanmuganathan K, Boyd-Kranis R, Scalea TM, Mirvis SE. CT Findings after Emboliza-tion for Blunt Splenic Trauma. Journal of Vascular and Interventional Radiology 2001; 12(2):209-214.
X. Preece S, Lungren MP, Miller Jr M, Smith TP, Kim CY. Coil embolization of the splenic artery: long-term impact on splenic volume Journal of Vascular and Interventional Radiology 2013; 24(4):S135-S136.
XI. Hicks, MD. Splenic Arterial Interventions: Ana-tomy, Indications, Technical Considerations, and Potential Complications. RadioGraphics 2005; 25:191–211.
XII. Nio M, Hayashi Y, Sano N, Ishii T, Sasaki H, Ohi R. Long-term efficacy of partial splenic emboliza-tion in children. Journal of Pediatric Surgery 2003; 38(12):1760-2.
XIII. Ekeh AP, Khalaf S, Ilyas S, Kauffman S, Walusim-bi M, McCarthy MC. Complications arising from splenic artery embolization a review of an 11-year experience. The American Journal of Surgery 2013; 205(3):250-4.
Derechos de autor 2014 Revista Argentina de Reumatología
Esta obra está bajo licencia internacional Creative Commons Reconocimiento-NoComercial-SinObrasDerivadas 4.0.
